DPI

Representative image: A dry powder inhaler prototype is shown in a pharmaceutical research setting, reflecting Phillips Medisize’s focus on connected inhaler innovation, device-formulation alignment, and patient-centric respiratory drug delivery at RDD 2026.

Medical Devices & Diagnostics

Phillips Medisize targets formulation-device risk as inhaled therapies grow more complex

by Pallavi Madhiraju
May 10, 2026
0 Comments

Inhalers are getting smarter, but complexity can backfire. Phillips Medisize is betting DPI success starts with patient-centric design.

Read More

Aptar Pharma's Orbital DPI selected for COVIRIX Medical pandemic antiviral development

Pharma & Biotech

Aptar Pharma and COVIRIX Medical partner to develop inhaled broad-spectrum antiviral treatment

by Pallavi Madhiraju
March 13, 2026
0 Comments

Aptar Pharma and COVIRIX Medical announce a DPI feasibility collaboration for inhaled broad-spectrum antivirals. Read the analysis.

Read More